Spliceosome Protein (SRp) Regulation of Glucocorticoid Receptor Isoforms and Glucocorticoid Response in Human Trabecular Meshwork Cells
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
PURPOSE: Glaucoma is a leading cause of visual impairment and blindness, with elevated intraocular pressure (IOP) as a major causative risk factor. Glucocorticoid (GC) therapy causes morphologic and biochemical changes in the trabecular meshwork (TM), an ocular tissue involved in regulating IOP, which can lead to the development of glaucoma in susceptible individuals (steroid responders). Steroid responders comprise 40% of the general population and are at higher risk of developing glaucoma. In addition, a majority of glaucoma patients are steroid responders. Differential distribution of various isoforms of GC receptor (GR) may be responsible for this heterogeneity in the steroid response. The alternatively spliced GRβ isoform acts as dominant negative regulator of classical GRα transcriptional activity. mRNA splicing is mediated by spliceosomes, which include serine-arginine rich proteins (SRps). The purpose of this study was to determine whether specific SRps regulate levels of these isoforms and thereby GC response in TM cells. METHODS: Quantitative RT-PCR, Western blot analysis, and immunocytochemistry were used to determine the differential expression of different SRps (SRp20, 30c, and 40) in human normal and glaucomatous TM cell strains. Bioinformatics was used to find putative binding sites for SRp20 and SRp40 on exon 9 of the GR gene. A peptide modulator of splicing (bombesin) and SRp expression vectors were used to modulate SRp levels and determine their effects on GRα/GRβ ratios as well as dexamethasone (DEX) responsiveness via GRE- luciferase reporter activity, fibronectin, and myocilin induction in TM cells. RESULTS: SRp20, SRp30c, and SRp40 regulate GR splicing and the GC response in TM cells. Modulation of SRp levels altered the GRβ/α ratio that correlated with DEX responsiveness. Bombesin decreased SRp20; increased SRp30c, SRp40 levels, and GRβ/α ratio, and suppressed DEX response in TM cells. CONCLUSIONS: Relative levels of SRp20, SRp30c, and SRp40 in TM cells control differential expression of the two alternatively spliced isoforms of the GR and thereby regulate GC responsiveness. Different levels and/or activities of these SRps may account for differential GC sensitivity among the normal and glaucoma populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but several studies have implicated the involvement of the splicing factor, SRp30c51, 52.”
From Corticosteroids (2016) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cartegni, L., & Krainer, A. R. (2002) · Nature Genetics · doi:10.1038/ng854 · Cited by 730
The Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Sar, M., & Cidlowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9550 · Cited by 562 · cited 2×
“In fact, GR functions as a dominant negative regulator of GR transcriptional activity.(21) GR levels are elevated in a variety of GC resistant diseases, including asthma,(22) rheumatoid arthritis,(23) and inflammatory bowel disease,(24) among others.”
BackgroundA specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm
Cáceres, J. F., Screaton, G. R., & Krainer, A. R. (1998) · Genes & Development · doi:10.1101/gad.12.1.55 · Cited by 493
Llorente, L., Richaud-Patin, Y., García-Padilla, C., Claret, E., Jakez-Ocampo, J., Cardiel, M. H., Alcocer-Varela, J., Grangeot-Keros, L., Alarcón-Segovia, D., Wijdenes, J., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1790::aid-anr15>3.0.co;2-2 · Cited by 461
Intraocular pressure response to topical corticosteroids.
Mf, A., & BECKER, B. A. (1965) · PubMed · Cited by 422
Ward, A. J., & Cooper, T. A. (2010) · The Journal of Pathology · doi:10.1002/path.2649 · Cited by 414 · cited 1×
“A spliceosome is composed of approximately 100 proteins, collectively known as splicing factors, in addition to the five small nuclear ribonucleoprotein particles (snRNPs).(32) The critical balance of these serine/arginine-rich proteins (SRp) and snRNPs is necessary for controlling the level of exon inclusion/exclusio…”
BackgroundA novel role for shuttling SR proteins in mRNA translation
Sanford, J. R., Gray, N. K., Beckmann, K., & Cáceres, J. F. (2004) · Genes & Development · doi:10.1101/gad.286404 · Cited by 407
Nguyen, T. D., Chen, P., Huang, W. D., Chen, H., Johnson, D., & Polansky, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6341 · Cited by 387 · cited 1×
“A potent and well-established GC, dexamethasone (DEX) is known to induce the glaucoma gene myocilin (MYOC) in TM cells.(14,15) Physiologically characterized as potent regulators of metabolism, GCs are also used as potent anti-inflammatory, antiallergic and immune-suppressant agents.”
BackgroundPolansky, J. R., Fauss, D. J., Chen, P., Chen, H., Lütjen-Drecoll, E., Johnson, D., Kurtz, R. M., Ma, Z.-D., Bloom, E., & Nguyen, T. D. (1997) · Ophthalmologica · doi:10.1159/000310780 · Cited by 374
Increased Glucocorticoid Receptor β in Airway Cells of Glucocorticoid-insensitive Asthma
HAMID, Q. A., WENZEL, S. E., HAUK, P. J., TSICOPOULOS, A., WALLAERT, B., LAFITTE, J.-J., CHROUSOS, G. P., SZEFLER, S. J., & LEUNG, D. Y. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9804131 · Cited by 292
Clark, A. F., Wilson, K., McCartney, M. D., Miggans, S. T., Kunkle, M., & Howe, W. E. (1994) · PubMed · Cited by 288
Self-citationThe Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1
Michlewski, G., Sanford, J. R., & Cáceres, J. F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.013 · Cited by 277
(2001) · PubMed · Cited by 266
Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma
Wordinger, R. J., & Clark, A. F. (1999) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00035-4 · Cited by 260 · cited 2×
“Approximately 4% to 6% of the general population develop a large increase ( 15 mm Hg) in intraocular pressure (IOP) after topical ocular GC administration for 4 to 6 weeks, while one-third of the population develops moderate pressure rise (6–15 mm Hg).(17,18) These individuals are categorized as steroid responders.”
BackgroundSelf-citationThe role of steroids in outflow resistance
Clark, A. F., & Wordinger, R. J. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.004 · Cited by 256 · cited 1×
“A number of laboratories have studied the effects of GCs on the TM to better understand steroid glaucoma and POAG because of the similarities in clinical phenotypes as well as the similar morphologic and biochemical changes in the TM.(46) There is considerable heterogeneity in an individual’s response to GCs, and appr…”
BackgroundSelf-citationHonda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T., & Kohgo, Y. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70172-7 · Cited by 252
Effects of TGF-β2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma
Wordinger, R. J., Fleenor, D. L., Hellberg, P. E., Pang, I.-H., Tovar, T. O., Zode, G. S., Fuller, J. A., & Clark, A. F. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0296 · Cited by 225 · cited 1×
“Real-time PCR was performed as described previously.(41) Briefly, 2.”
MethodSelf-citationClark, A. F., Brotchie, D., Read, A. T., Hellberg, P., English‐Wright, S., Pang, I., Ethier, C. R., & Grierson, I. (2005) · Cell Motility · doi:10.1002/cm.20049 · Cited by 207
Self-citationA nucleo‐cytoplasmic SR protein functions in viral IRES‐mediated translation initiation
Bedard, K. M., Daijogo, S., & Semler, B. L. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601494 · Cited by 178
The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells.
Steely, H. T., Browder, S., Julian, M. B., Miggans, S. T., Wilson, K. L., & Clark, A. F. (1992) · PubMed · Cited by 175
Self-citationStage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis
Stickeler, E., Kittrell, F., Medina, D., & Berget, S. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202671 · Cited by 175
Zhang, X., Ognibene, C. M., Clark, A. F., & Yorio, T. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.022 · Cited by 159 · cited 3×
“We previously suggested that the molecular mechanism responsible for these differences in steroid responsiveness is due to differential expression of the GR isoform between normal and glaucoma TM cells.(9,31) However, the mechanisms responsible for this differential expression of GR in TM cells had not been previously…”
BackgroundSelf-citationPreliminary characterization of a transformed cell strain derived from human trabecular meshwork
Pang, I.-H., Shade, D. L., Clark, A. F., Steely, H. T., & DeSantis, L. M. (1994) · Current Eye Research · doi:10.3109/02713689409042398 · Cited by 138
Self-citationDexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells
Wilson, K., McCartney, M. D., Miggans, S. T., & Clark, A. F. (1993) · Current Eye Research · doi:10.3109/02713689309020383 · Cited by 121
Self-citationHamilos, D. L., Leung, D. Y. M., Muro, S., Kahn, A. M., Hamilos, S. S., Thawley, S. E., & Hamid, Q. A. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.116428 · Cited by 116
Cultured human trabecular meshwork cells express functional growth factor receptors.
Wordinger, R. J., Clark, A. F., Agarwal, R., Lambert, W. S., McNatt, L. G., Wilson, S. E., Qu, Z., & Fung, B. K.-K. (1998) · PubMed · Cited by 112
Self-citationExpression of splicing factors in human ovarian cancer
Fischer, D., Noack, K., Runnebaum, I. B., Watermann, D. O., Kieback, D., Stamm, S., & Stickeler, E. (2004) · Oncology Reports · doi:10.3892/or.11.5.1085 · Cited by 106
Cytoskeletal Changes in Cultured Human Glaucoma Trabecular Meshwork Cells
Clark, A. F., Miggans, S. T., Wilson, K., Browder, S., & McCartney, M. D. (1995) · Journal of Glaucoma · doi:10.1097/00061198-199506000-00007 · Cited by 104
Self-citationHoare, M., Grierson, I., Brotchie, D., Pollock, N., Cracknell, K. P. B., & Clark, A. F. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2706 · Cited by 103 · cited 1×
“GCs also reorganize the cytoskeleton to form cross-linked actin networks (CLANs) in cultured human TM cells(10) and tissues(11) that mimic CLANs observed in cultured glaucoma (GTM) cells(12) as well as TM tissue from glaucoma eyes.(13) A potent and well-established GC, dexamethasone (DEX) is known to induce the glauco…”
BackgroundSelf-citationLewis, J. M., Priddy, T., JUDD, J. H., Gordon, M. O., Kass, M. A., Kolker, A. E., & Becker, B. (1988) · American Journal of Ophthalmology · doi:10.1016/0002-9394(88)90595-8 · Cited by 96 · cited 1×
“In addition, it has also been observed that steroid-responsive nonglaucomatous individuals are at much higher risk of developing POAG compared with steroid nonresponders.(19,20) The molecular mechanisms underlying this differential sensitivity between normal and POAG patients toward GCs are poorly understood.”
BackgroundDexamethasone decreases phagocytosis by human trabecular meshwork cells in situ.
Matsumoto, Y., & Johnson, D. H. (1997) · PubMed · Cited by 94
Basic Sciences in Clinical Glaucoma: Steroids, Ocular Hypertension, and Glaucoma
Clark, A. F. (1995) · Journal of Glaucoma · doi:10.1097/00061198-199510000-00010 · Cited by 89 · cited 2×
“In addition to GC potency, duration and route of administration, GC-induced OHT depends on the inherent GC sensitivity of the patient.(16) Approximately 4% to 6% of the general population develop a large increase ( 15 mm Hg) in intraocular pressure (IOP) after topical ocular GC administration for 4 to 6 weeks, while o…”
BackgroundSelf-citationLow Glucocorticoid Receptor α/β Ratio in T-cell Lymphoblastic Leukemia
Longui, C., Vottero, A., Adamson, P., Cole, D., Kino, T., Monte, O., & Chrousos, G. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978661 · Cited by 86
Ghigna, C., Moroni, M., Porta, C., Riva, S., & Biamonti, G. (1998) · PubMed · Cited by 80
The Prognosis of Corticosteroid-Responsive Individuals
Kitazawa, Y., & Horie, T. (1981) · Archives of Ophthalmology · doi:10.1001/archopht.1981.03930010819005 · Cited by 72 · cited 1×
“In addition, it has also been observed that steroid-responsive nonglaucomatous individuals are at much higher risk of developing POAG compared with steroid nonresponders.(19,20) The molecular mechanisms underlying this differential sensitivity between normal and POAG patients toward GCs are poorly understood.”
BackgroundZhang, X., Clark, A. F., & Yorio, T. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0571 · Cited by 71 · cited 5×
“We previously suggested that the molecular mechanism responsible for these differences in steroid responsiveness is due to differential expression of the GR isoform between normal and glaucoma TM cells.(9,31) However, the mechanisms responsible for this differential expression of GR in TM cells had not been previously…”
BackgroundResultSelf-citationDowling, D., Nasr-Esfahani, S., Tan, C., O’Brien, K., Howard, J. L., Jans, D. A., Purcell, D. F. J., Stoltzfus, C. M., & Sonza, S. (2008) · Retrovirology · doi:10.1186/1742-4690-5-18 · Cited by 68
Xu, Q., Leung, D. Y. M., & Kisich, K. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300824200 · Cited by 59
Increased Plasma Free Cortisol in Ocular Hypertension and Open Angle Glaucoma
Schwartz, B., McCarty, G., & Rosner, B. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060080062029 · Cited by 54
Aqueous humour and plasma cortisol levels in glaucoma and cataract patients
Rozsival, P., Hampl, R., Obenberger, J., Stárka, L., & Rehák, S. (1981) · Current Eye Research · doi:10.3109/02713688109019976 · Cited by 49
Zhu, J., Gong, J. Y., Goodman, O. B., Cartegni, L., Nanus, D. M., & Shen, R. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.04.016 · Cited by 47 · cited 1×
“Bombesin has been shown to alter SRp30c levels and affect GR splicing in PC-3 cells.(33) To study the effect of SRps on GR splicing in TM, we treated TM cell lines (n 5) with increasing concentrations of bombesin (0–10 M) for 24 hours.”
BackgroundAlternative splicing in exon 9 of glucocorticoid receptor pre-mRNA is regulated by SRp40
Yan, X., Tang, C., Huang, Y., Fang, H., Yu, Z., Wu, L., & Liu, R. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9529-z · Cited by 42
Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients
Watanuki, T., Funato, H., Uchida, S., Matsubara, T., Kobayashi, A., Wakabayashi, Y., Otsuki, K., Nishida, A., & Watanabe, Y. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.003 · Cited by 40
Fingert, J. H., Alward, W. L. M., Wang, K., Yorio, T., & Clark, A. F. (2010) · PubMed Central · Cited by 38
Self-citationSouthren, A. L., Gordon, G. G., Munnangi, P. R., Vittek, J., Schwartz, J., Monder, C., Dunn, M. W., & Weinstein, B. I. (1983) · PubMed · Cited by 35
Defects in cortisol-metabolizing enzymes in primary open-angle glaucoma.
Weinstein, B. I., Munnangi, P. R., Gordon, G. G., & Southren, A. L. (1985) · PubMed · Cited by 33
Hägg, P. M., Hurskainen, T., Palatsi, R., Ilves, M., & Oikarinen, A. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09518.x · Cited by 31
Weinstein, B. I., Iyer, R., Binstock, J. M., Hamby, C. V., Schwartz, I. S., MOY, F. H., Wandel, T. L., & SOUTHREN, L. A. (1996) · Experimental Eye Research · doi:10.1006/exer.1996.0005 · Cited by 25
Ray, S., Mehra, K. S., Misra, S., & Singh, R. (1977) · PubMed · Cited by 21
Liu, Y., Song, L., & Li, B. (2001) · PubMed · Cited by 12
Liu, Y., Song, L., & Li, B. (2001) · PubMed · Cited by 12
Genetic defect in cortisol metabolism in primary open angle glaucoma.
Southren, A. L., Gordon, G. G., & Weinstein, B. I. (1985) · PubMed · Cited by 9
Zhao, Y., Zhou, J., & Li, X. (2005) · PubMed · Cited by 5
Xie, Y., Jiao, Y., Xu, X., Wang, H., & Yin, J. (2007) · PubMed · Cited by 2
Research works printed but not linked: 2
- SRp20 Santa Cruz Biotech, Santa Cruz, CA; SC-73059; mouse monoclonal 1:200 for WB; 1:50 for ICC SRp30c Santa Cruz Biotech, Santa Cruz, CA; SC134036; rabbit polyclonal 1:200 for WB; 1:50 for ICC SRp40 Novus Biologicals, Littleton, CO; H00006430-B01P; mouse polyclonal 1:500 for WB; 1:100 for ICC GR␣ Santa Cruz Biotech, Santa Cruz, CA; SC-1002; rabbit polyclonal 1:300 for WB; 1:50 for ICC GR Custom-made; rabbit polyclonal 1:2000 for WB; 1:500 for ICC Fibronectin Millipore, Billerica, MA; AB1945; rabbit polyclonal 1:500 for WB; 1:500 for ELISA Myoclin Santa Cruz Biotech, Santa Cruz, CA; SC-20976; goat polyclonal 1:500 for WB GAPDH Cell Signaling, Boston, MA; 14C10; rabbit monoclonal 1:1000 for WB -Actin Millipore, Billerica, MA; MAB 1501; mouse monoclonal 1:500 for WB References
- Neugebauer KM, Merrill JT, Wener MH, Lahita RG, Roth MB. SR proteins are autoantigens in patients with systemic lupus erythem- atosus. Importance of phosphoepitopes. Arthritis Rheum. 2000; 43:1768 -1778.
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“The molecular factors that control GRβ expression are poorly understood, but several studies have implicated the involvement of the splicing factor SRp30c (61-63).”
BackgroundRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
The many faces of the trabecular meshwork cell
Stamer, W. D., & Clark, A. F. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2016.07.009 · Cited by 261
“1, which increases splicing of GRβ in cultured TM cells (Jain et al., 2012).”
BackgroundSelf-citationThe RNAissance family: SR proteins as multifaceted regulators of gene expression
Howard, J. M., & Sanford, J. R. (2015) · WIREs RNA · doi:10.1002/wrna.1260 · Cited by 247
Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma
Zode, G. S., Sharma, A. B., Lin, X., Searby, C. C., Bugge, K., Kim, G. H., Clark, A. F., & Sheffield, V. C. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69774 · Cited by 168
“Several studies have suggested that differences in the levels of alternatively spliced glucocorticoid receptor isoforms regulate glucocorticoid responsiveness in TM cells (37, 49).”
Self-citation
Metadata
- Authors
- Jain, A., Wordinger, R. J., Yorio, T., & Clark, A. F.
- Affiliations
- University of North Texas Health Science Center (US)
- Corresponding author
- Jain, Ankur
- Wordinger, Robert J.
- Yorio, Thomas
- Clark, Abbot F.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2012-02-21
- Volume
- 53
- Issue
- 2
- Pages
- 857
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- PMC
- PMC3317424
- OpenAlex
- W2057323820
- Cited by
- 46
- References
- 54
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 4 · 2021: 6 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 2 · 2012: 1
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Eye Institute (R01EY016242, EY016242)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoid receptor isoforms, alternative splicing, SR proteins, SRp20, SRp40, glucocorticoid response, trabecular meshwork cells, glaucoma, intraocular pressure, bombesin, dexamethasone, myocilin
- MeSH terms
- Serine-Arginine Splicing Factors, Cells, Cultured, Electrophoresis, Agar Gel, Enzyme-Linked Immunosorbent Assay, Gene Expression Regulation, Gene Frequency, Glaucoma, Glucocorticoids, Humans, Immunohistochemistry, Nuclear Proteins, Receptors, Glucocorticoid, RNA, Messenger, Trabecular Meshwork, Blotting, Western, RNA-Binding Proteins, Spliceosomes, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.